Form 4 for MD Pediatrix Medical Group, Inc.
Accepted 2022-03-03 00:00:00 ET · period of report 2022-03-01 · accession 0001209191-22-015588 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-03-03 | 2022-03-01 | MD | ORDAN MARK S | CEO, Dir | A - Grant | $0.00 | +152.5K | 313.2K | +95% | $0 |
| 2022-03-03 | 2022-03-01 | MD | ORDAN MARK S | CEO, Dir | F - Tax | $23.47 | -20.7K | 368.8K | -5% | -$485.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-03-01 | A | A | 76,253 | $0.00 | 389,502 | D | — | — | |
| 2 | Common | Common Stock | 2022-03-01 | A | A | 76,253 | $0.00 | 313,249 | D | — | — | (F2) Includes 28,571 restricted shares granted pursuant to the Plan in connection with achievement in excess of target of specified performance-based criteria for the performance period from January 1, 2021 through December 31, 2021. |
| 3 | Common | Common Stock | 2022-03-01 | F | D | 20,691 | $23.47 | 368,811 | D | — | — |